FDA's ANDA Steering Cmte.
Executive Summary
Met with the Generic Pharmaceutical Industry Assn. and Natl. Pharmaceutical Alliance Oct. 16 for recommendations on implementation of the ANDA/Patent Restoration bill. Cmte. is also scheduled to meet with PMA Nov. 6 and NAPM Nov. 8. Headed by Deputy Com. Novitch, the cmte. also includes Generic Drug Div. Director Marvin Seife, Office of Drug Standards Director Peter Rheinstein, Associate Com. for Legislation and Information Robert Wetherell, Associate Com. for Management and Operations Gerald Meyer and Office of Drug Standards Deputy Director James Morrison